CURRICULUM VITAE. Key Qualifications: Gastroenterology, Hepatology, Pancreatobiliary system

Transcription

1 CURRICULUM VITAE Personal Details Surname: BAHCECIOGLU First Name: Ibrahim Halil Akademic title/ position: Prof. Dr. Key Qualifications: Gastroenterology, Hepatology, Pancreatobiliary system Research Interest: Fatty liver, portal hypertension, viral hepatitis Contact Details: Work Address: Firat University, Faculty of Medicine, Division of Gastroenterology Name of Hospital: Firat University Hospital Town: Elazig Country: Turkey Post Code: Phone/Fax: Date of Birth: Place and Country of Birth: PALU/TÜRKĐYE Country of Citizenship: TÜRKĐYE Country of Training: TÜRKĐYE First Language: TÜRKÇE Languages: ĐNGĐLĐZCE Akademic Details Faculty/University ( name and address)

2 HACETTEPE UNIVERSITY, FACULTY OF MEDICINE-ANKARA-TURKEY Date of Graduation: Postgraduate Training: ( Name and address of Center and Supervisor [s] in charge of Training) ISTANBUL UNIVERSITY, FACULTY OF CERRAHPASA MEDICAL, DEPARTMENT OF INTERNAL MEDICINE FIRAT UNIVERSITY, FACULTY OF MEDICINE, DIVISION OF GASTROENTEROLOGY. SUPERVISOR IN CHARGE OF TRAINING: From To From to Title of thesis: Fatty liver: 100 cases Role of ocreotide on the model experimental liver fibrosis Memberships: Turkish gastroenterology association Turkish liver study association International Publications 1. Bahçecioğlu IH, Üstündağ B, Özercan Đ, Ergül E, Baydaş G, Akdere T, Demir A. Protective effect of ginkgo biloba extract on CCl4 induced liver damage. Hepatology Res 1999; 15: Bahçecioğlu IH, Demir A, Üstündağ B, Đlhan M, Baydaş G, Canatan H, Özercan Đ. Protective effect of L-carnitine on alcoholic fatty liver in rats. Med Sci Res 1999; 27: Dönder E, Baydaş G, Özkan Y, Erçel E, Yalnız M, Doğan H, Bahçecioğlu IH, Investigation of antioxidant and glucometabolic effects on melatonin in experimental diabetes mellitus. Biomed Res 1999; 10: Yılmaz S, Bahçecioğlu IH. Lipid peoxidation, antioxidant enzymes and pyruvate kinase activity in rats with carbon tetrachloride-induced cirrhosis. Turk J Vet Anim Sci 2000;24: Ustundag B, Canatan H, Cinkilinc N, Halifeoglu I, Bahcecioglu IH. Angiotensin converting enzyme (ACE) activity levels in insulin-independent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy. Cell Biochem Funct. 2000; 18: Ozercan IH, Bahcecioglu IH, Ozercan MR, Bozlak N, Dogan C, Yekeler H. Proliferating cell nuclear antigen and nucleolar organizer region for differential diagnosis of dysplasia and adenocarcinoma in gastric biopsies. Indian J Gastroenterol.2000;19:57-60.

3 7. Dogukan A, Akpolat N, Celiker H, Ilhan N, Halil Bahcecioglu I, Gunal AI. Protective effect of interferon-alpha on carbon tetrachloride-induced nephrotoxicity. J Nephrol.2003;16: Yalcin K, Degertekin H, Bahcecioglu IH, Demir A, Aladag M, Yildirim B, Horasanli S, Ciftci S, Badur S. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey. Infection 2004;32: Demirdag K, Bahcecioglu IH, Ozercan IH, Ozden M, Yilmaz S, Kalkan A. Role of L-carnitine in the prevention of acute liver damage induced by carbon tetrachloride in rats. J Gastroenterol Hepatol. 2004;19: Celebi S, Acik Y, Deveci SE, Bahcecioglu IH, Ayar A, Demir A, Durukan P. Epidemiological features of irritable bowel syndrome in a Turkish urban society. J Gastroenterol Hepatol. 2004;19: Bahcecioglu IH, Yalniz M, Ataseven H, Bulbuller N, Kececi M, Demirdag K, Ozercan I, Ustundag B. TNF-alpha and leptin in experimental liver fibrosis models induced by carbon tetrachloride and by common bile duct ligation. Cell Biochem Funct. 2004;22: Bahçecioğlu IH, Yalnız M, Ataseven H, Đlhan N, Özercan ĐH. Seçkin D, Şahin K. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis. Hepatogastroenterology. 2005;52: Bahçecioğlu IH, Yalnız M, Đlhan N. Ataseven H, Özercan IH. Levels of Serum Vitamin A, Alpha Tocopherol and Malondialdehyde in patients with non-alcoholic steatohepatitis: relationship with histopathologic severity. Int J Clin Pract 2005;59: Bolukbas FF, Bolukbas C, Zeyrek F, Aslan M, Bahcecioglu HI, Ozardali I. High rate of seropositivity of Chlamydia pneumoniae IgA in male patients with nonalcoholic steatohepatitis. Dig Dis Sci. 2005;50: Ozercan IH, Dagli AF, Ustundag B, Ozercan MR, Bahcecioglu IH, Celik H, Yalniz M, Poyrazoglu OK, Ataseven H. Does instant coffee prevent acute liver injury induced by carbon tetrachloride (CCl (4). Hepatol Res.2006;35: Bahcecioglu IH, Koruk M, Yilmaz O, Bolukbas C, Bolukbas F, Tuncer I, Ataseven H, Yalcin K, Ozercan IH. Demographic and clinicopathological characteristics of nonalcoholic fatty liver disease in the East-Southeastern Anatolia regions in Turkey. Med Princ Pract. 2006;15: Yalniz M, Bahcecioglu IH, Ataseven H, Ustundag B, Ilhan F, Poyrazoglu OK, Erensoy A. Serum adipokine and ghrelin levels in non alcoholic steatohepatitis. Mediators Inflamm. 2006;2006(6): Ataseven H, Bahcecioglu IH, Kuzu N, Yalniz M, Celebi S, Erensoy A, Ustundag B. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm. 2006;2006(4): Kuzu N, Metin K, Dagli AF, Akdemir F, Orhan C, Yalniz M, Ozercan IH, Sahin K, Bahcecioglu IH. Protective role of genistein in acute liver damage induced by carbon tetrachloride. Mediators Inflamm.2007; 2007:

4 20. Poyrazoglu OK, Bahcecioglu IH, Dagli AF, Ataseven H, Celebi S, Yalniz M. Heterotopic gastric mucosa (inlet patch): endoscopic prevalence, histopathological, demographical and clinical characteristics.int J Clin Pract May 29; [Epub ahead of print] 21- Ustundag B, Bahcecioglu IH, Sahin K, Duzgun S, Koca S, Gulcu F, Ozercan IH. Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental non alcoholic steatohepatitis model. Dig Dis Sci. 2007;52: Yalniz M, Bahcecioglu IH, Kuzu N, Celebi S, Ataseven H, Ustundag B, Ozercan IH, Sahin K. Amelioration of steatohepatitis with pentoxifylline in a novel nonalcoholic steatohepatitis model induced by high-fat diet. Dig Dis Sci ;52: Kuzu N, Bahcecioglu IH, Dagli AF, Ozercan IH, Ustündag B, Sahin K. Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet. J Gastroenterol Hepatol ;23(8 Pt 2): Poyrazoglu OK, Ataseven H, Bektas S, Aydin A, Yalniz M, Celebi S, Bahcecioglu IH. Portal hypertension due to Echinococcus alveolaris: a case report. Acta Medica (Hradec Kralove). 2007;50: Yalniz M, Bahcecioglu IH, Kuzu N, Poyrazoglu OK, Bulmus O, Celebi S, Ustundag B, Ozercan IH, Sahin K. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. J Gastroenterol Hepatol ;22(11): Bahcecioglu IH, Ataseven H, Aygen E, Coskun S, Kuzu N, Ilhan F. Fasciola hepatica case with hemobilia. Acta Medica (Hradec Kralove). 2007;50(2): Koca SS, Bahcecioglu IH, Poyrazoglu OK, Ozercan IH, Sahin K, Ustundag B. The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. Inflammation ;31: Bahcecioglu IH, Koca SS, Poyrazoglu OK, Yalniz M, Ozercan IH, Ustundag B, Sahin K, Dagli AF, Isik A. Hepatoprotective effect of infliximab, an anti-tnf-alpha agent, on carbon tetrachlorideinduced hepatic fibrosis. Inflammation ;31: Tozun N, Atug O, Imeryuz N, Hamzaoglu HO, Tiftikci A, Parlak E, Dagli U, Ulker A, Hulagu S, Akpinar H, Tuncer C, Suleymanlar I, Ovunc O, Hilmioglu F, Aslan S, Turkdogan K, Bahcecioglu HI, Yurdaydin C; Members of the Turkish IBD Study Group. Clinical Characteristics of Inflammatory Bowel Disease in Turkey: A Multicenter Epidemiologic Survey. J Clin Gastroenterol Aug Bahcecioglu IH, Yalniz M, Ataseven H, Kuzu N, Ilhan F, Erensoy A. Biliary Fasciolosis: A Report of Tree Cases Diagnosed by ERCP. Acta Parasitologica Turcica (Baskıda). Presentations at International Scientific Meetings

5 1. Bahçecioğlu ĐH, Yalnız M, Đlhan N, Ataseven H, Özercan ĐH. Serum level of Malondialdehyde, Vitamin A, alpha Tocopherol in patients with non-alcoholic steatohepatitis. Falk Symposium, October 17-29,2003, Freiburg. 2. Yalcin K, Degertekin H, Bahcecioglu IH, Demir A. Risk factors, clinical and virological characteristics of hepatitis delta virus infection in Turkey J Hepatol 2003; 38: 631 (Suppl. 2 ). 3. Yalcin K, Bahçecioğlu ĐH, Aladağ M, Yildirim B, Değertekin H, Demir A, Badur S. Clinical profile, significance, and distribution of hepatitis B virus Genotypes among patients with chronic hepatitis B virus Infection. 12th World Congress Of The Intenational Association of Surgeons an Gastroenterologists. Hepato-Gastroenterology 2002: 49 (Suppl 2). 4. Yalniz M, Ataseven H, Bahcecioglu IH, Özercan ĐH. Is there a value of dual-energy X-ray absorptiometry in predicting the histopathologic severity of non-alcoholic steatohepatitis? J Hepatol : 705 (Suppl. 2). 5. Ataseven H, Yildirim MH, Yalniz M, Bahçecioğlu ĐH, Ozercan IH, Celebi S and Demir A. Correlation between calibrated computerized tomographic findings and histopathologic grade/stage in non-alcoholic steatohepatitis J Hepatol : 706 (Suppl 2). 6. Kuzu N, Bahçecioğlu ĐH, Metin K, Özercan ĐH, Tuzcu M, Yalniz M, Ustundag B, Sahin K. Role of melatonin in treatment of nonalcoholic steatohepatitis in rats induced by high fat diet. J Hepatol 2007; 46: 263.